{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:29:16Z","timestamp":1791462556859,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10620-024-08722-0","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:59:38Z","timestamp":1732003178000},"page":"154-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review"],"prefix":"10.1007","volume":"70","author":[{"given":"Kaia C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia-Stefania","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Moylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"8722_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","volume":"61","author":"ZA Sherif","year":"2016","unstructured":"Sherif ZA, Saeed A, Ghavimi S et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Dig Dis Sci. 2016;61:1214\u20131225. https:\/\/doi.org\/10.1007\/s10620-016-4143-0","journal-title":"Dig Dis Sci."},{"key":"8722_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155402","volume":"141","author":"B Chong","year":"2023","unstructured":"Chong B, Kong G, Shankar K et al. The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000\u20132019. Metabolism. 2023;141:155402.","journal-title":"Metabolism."},{"key":"8722_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew NWS, Ng CH, Tan DJH et al. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab. 2023;35:414-428.e3.","journal-title":"Cell Metab."},{"key":"8722_CR4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/liv.15188","volume":"42","author":"TM Farahat","year":"2022","unstructured":"Farahat TM, Ungan M, Vilaseca J et al. The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint. Liver International. 2022;42:1259\u20131267.","journal-title":"Liver International."},{"key":"8722_CR5","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.3390\/jcm10215019","volume":"10","author":"M Talens","year":"2021","unstructured":"Talens M, Tumas N, Lazarus JV, Benach J, Peric\u00e0s JM. What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review. JCM. 2021;10:5019.","journal-title":"JCM."},{"key":"8722_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR et al. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2018;16:198-210.e2.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"8722_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120846","volume":"306","author":"Y-H Han","year":"2022","unstructured":"Han Y-H, Choi H, Kim H-J, Lee M-O. Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice. Life Sci. 2022;306:120846.","journal-title":"Life Sci."},{"key":"8722_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.freeradbiomed.2021.06.024","volume":"172","author":"TA Mazi","year":"2021","unstructured":"Mazi TA, Borkowski K, Newman JW et al. Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study. Free Radical Biology and Medicine. 2021;172:490\u2013502.","journal-title":"Free Radical Biology and Medicine."},{"key":"8722_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/apt.17219","volume":"56","author":"A Kardashian","year":"2022","unstructured":"Kardashian A, Dodge JL, Terrault NA. Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population-based study. Alimentary Pharmacology & Therapeutics 2022;56:1383\u20131393.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"8722_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/MPG.0000000000001581","volume":"65","author":"M Mouzaki","year":"2017","unstructured":"Mouzaki M, Ling SC, Schreiber RA, Kamath BM. Management of Pediatric Nonalcoholic Fatty Liver Disease by Academic Hepatologists in Canada: A Nationwide Survey. J Pediatr Gastroenterol Nutr. 2017;65:380\u2013383.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8722_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11892-015-0674-6","volume":"15","author":"M Lazo","year":"2015","unstructured":"Lazo M, Bilal U, Perez-Escamilla R. Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin. Curr Diab Rep. 2015;15:116.","journal-title":"Curr Diab Rep."},{"key":"8722_CR12","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u20131986.","journal-title":"Hepatology."},{"key":"8722_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/MEG.0000000000001735","volume":"33","author":"SK Satapathy","year":"2021","unstructured":"Satapathy SK, Marella HK, Heda RP et al. African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians. European Journal of Gastroenterology & Hepatology. 2021;33:388\u2013398.","journal-title":"European Journal of Gastroenterology & Hepatology."},{"key":"8722_CR14","doi-asserted-by":"publisher","first-page":"NP1793","DOI":"10.1177\/1010539513483830","volume":"27","author":"J Wang","year":"2015","unstructured":"Wang J, Chiu W-H, Chen R-C, Chen F-L, Tung T-H. The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital. Asia Pac J Public Health 2015;27:NP1793-1804.","journal-title":"Asia Pac J Public Health"},{"key":"8722_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.10.011","volume":"45","author":"N Motamed","year":"2021","unstructured":"Motamed N, Nikkhah M, Karbalaie Niya MH et al. The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. Clin Res Hepatol Gastroenterol. 2021;45:101567.","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"8722_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MCG.0000000000001585","volume":"57","author":"AD Schreiner","year":"2023","unstructured":"Schreiner AD, Livingston S, Zhang J et al. Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. Journal of Clinical Gastroenterology. 2023;57:89\u201396.","journal-title":"Journal of Clinical Gastroenterology."},{"key":"8722_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S2468-1253(21)00100-X","volume":"6","author":"NE Rich","year":"2021","unstructured":"Rich NE, Noureddin M, Kanwal F, Singal AG. Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA. The Lancet Gastroenterology & Hepatology. 2021;6:422\u2013424.","journal-title":"The Lancet Gastroenterology & Hepatology."},{"key":"8722_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.15403\/jgld.2014.1121.252.naf","volume":"25","author":"S Iacob","year":"2016","unstructured":"Iacob S, Ester C, Lita M, Ratziu V, Gheorghe L. Real-life Perception and Practice Patterns of NAFLD\/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists. J Gastrointestin Liver Dis. 2016;25:183\u2013189.","journal-title":"J Gastrointestin Liver Dis."},{"key":"8722_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/oby.20426","volume":"22","author":"ALC Schneider","year":"2014","unstructured":"Schneider ALC, Lazo M, Selvin E, Clark JM. Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity (Silver Spring) 2014;22:292\u2013299.","journal-title":"Obesity (Silver Spring)"},{"key":"8722_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.795421","volume":"8","author":"M Shaheen","year":"2021","unstructured":"Shaheen M, Schrode KM, Pan D et al. Sex-Specific Differences in the Association Between Race\/Ethnicity and NAFLD Among US Population. Front Med (Lausanne). 2021;8:795421.","journal-title":"Front Med (Lausanne)."},{"key":"8722_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335.","journal-title":"Hepatology."},{"key":"8722_CR22","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387\u20131395.","journal-title":"Hepatology."},{"key":"8722_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2021.9883","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang L, Li X, Wang Z et al. Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999\u20132018. JAMA. 2021;326:1\u201313.","journal-title":"JAMA."},{"key":"8722_CR24","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2021.15187","volume":"326","author":"J He","year":"2021","unstructured":"He J, Zhu Z, Bundy JD et al. Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999\u20132018. JAMA. 2021;326:1286\u20131298.","journal-title":"JAMA."},{"key":"8722_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13679-019-00349-x","volume":"8","author":"U Agbim","year":"2019","unstructured":"Agbim U, Carr RM, Pickett-Blakely O, Dagogo-Jack S. Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. Curr Obes Rep. 2019;8:243\u2013254.","journal-title":"Curr Obes Rep."},{"key":"8722_CR26","first-page":"286","volume":"20","author":"R Mahabaleshwarkar","year":"2022","unstructured":"Mahabaleshwarkar R, Liu T-L, McKillop IH, Spencer M. The Association Between Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease Diagnosis Varies by Race. Metab Syndr Relat Disord. 2022;20:286\u2013294.","journal-title":"Metab Syndr Relat Disord."},{"key":"8722_CR27","doi-asserted-by":"publisher","first-page":"1076730","DOI":"10.3389\/fphys.2023.1076730","volume":"14","author":"M Shaheen","year":"2023","unstructured":"Shaheen M, Schrode KM, Tedlos M et al. Racial\/ethnic and gender disparity in the severity of NAFLD among people with diabetes or prediabetes. Front Physiol. 2023;14:1076730.","journal-title":"Front Physiol."},{"key":"8722_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","volume":"6","author":"J-J Pan","year":"2014","unstructured":"Pan J-J, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World Journal of Hepatology. 2014;6:274\u2013283.","journal-title":"World Journal of Hepatology."},{"key":"8722_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/ijo.2017.309","volume":"42","author":"MG Browning","year":"2018","unstructured":"Browning MG, Khoraki J, Deantonio JH et al. Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes. International Journal of Obesity. 2018;42:926\u2013929.","journal-title":"International Journal of Obesity."},{"key":"8722_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4254\/wjh.v8.i20.827","volume":"8","author":"VVR Kanth","year":"2016","unstructured":"Kanth VVR, Sasikala M, Sharma M, Rao PN, Reddy DN. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. World Journal of Hepatology. 2016;8:827\u2013837.","journal-title":"World Journal of Hepatology."},{"key":"8722_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20131465.","journal-title":"Nat Genet."},{"key":"8722_CR32","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/cncr.31122","volume":"124 Suppl 7","author":"CG Tepper","year":"2018","unstructured":"Tepper CG, Dang JHT, Stewart SL et al. High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease. Cancer 2018;124 Suppl 7:1583\u20131589.","journal-title":"Cancer"},{"key":"8722_CR33","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.cgh.2019.04.034","volume":"17","author":"ER Yoo","year":"2019","unstructured":"Yoo ER, Ahmed A, Kim D. Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups. Clinical Gastroenterology and Hepatology. 2019;17:2176\u20132178.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"8722_CR34","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2174\/13816128113199990381","volume":"19","author":"P Dongiovanni","year":"2013","unstructured":"Dongiovanni P, Anstee QM, Valenti L. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des. 2013;19:5219\u20135238.","journal-title":"Curr Pharm Des."},{"key":"8722_CR35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/hep.26440","volume":"58","author":"ND Palmer","year":"2013","unstructured":"Palmer ND, Musani SK, Yerges-Armstrong LM et al. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology. 2013;58:966\u2013975.","journal-title":"Hepatology."},{"key":"8722_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0039-1679920","volume":"39","author":"S Sookoian","year":"2019","unstructured":"Sookoian S, Pirola CJ. Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics. Semin Liver Dis. 2019;39:124\u2013140.","journal-title":"Semin Liver Dis."},{"key":"8722_CR37","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.cgh.2019.02.007","volume":"17","author":"ER Kallwitz","year":"2019","unstructured":"Kallwitz ER, Tayo BO, Kuniholm MH et al. American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic\/Latino Adults. Clinical Gastroenterology and Hepatology. 2019;17:2301\u20132309.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"8722_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/liv.14387","volume":"40","author":"E Kallwitz","year":"2020","unstructured":"Kallwitz E, Tayo BO, Kuniholm MH et al. Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics\/Latinos. Liver International. 2020;40:889\u2013893.","journal-title":"Liver International."},{"key":"8722_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.971484","volume":"13","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Chong B, Ng CH et al. The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases. Front Genet. 2022;13:971484.","journal-title":"Front Genet."},{"key":"8722_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.numecd.2019.09.004","volume":"30","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Samargandy S, Zeb I et al. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race\/ethnicity matter? Findings from the MESA cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2020;30:114\u2013122.","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases."},{"key":"8722_CR41","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/oby.23478","volume":"30","author":"JM de Groot","year":"2022","unstructured":"de Groot JM, Geurtsen ML, Santos S, Jaddoe VWV. Ethnic disparities in liver fat accumulation in school-aged children. Obesity. 2022;30:1472\u20131482.","journal-title":"Obesity."},{"key":"8722_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jn\/nxz212","volume":"150","author":"I Golovaty","year":"2020","unstructured":"Golovaty I, Tien PC, Price JC et al. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. The Journal of Nutrition. 2020;150:91\u201398.","journal-title":"The Journal of Nutrition."},{"key":"8722_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4254\/wjh.v6.i5.263","volume":"6","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World Journal of Hepatology. 2014;6:263\u2013273.","journal-title":"World Journal of Hepatology."},{"key":"8722_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/osp4.634","volume":"9","author":"RG Kim","year":"2023","unstructured":"Kim RG, Khalili M. Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race\/ethnicity, and body mass. Obesity Science & Practice. 2023;9:190\u2013199.","journal-title":"Obesity Science & Practice."},{"key":"8722_CR45","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s10620-020-06501-1","volume":"66","author":"M Balakrishnan","year":"2021","unstructured":"Balakrishnan M, Seth A, Cortes-Santiago N et al. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021;66:2387\u20132393. https:\/\/doi.org\/10.1007\/s10620-020-06501-1","journal-title":"Dig Dis Sci."},{"key":"8722_CR46","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797.","journal-title":"Hepatology."},{"key":"8722_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008179","volume":"96","author":"W Dai","year":"2017","unstructured":"Dai W, Ye L, Liu A et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Medicine (Baltimore). 2017;96:e8179.","journal-title":"Medicine (Baltimore)."},{"key":"8722_CR48","doi-asserted-by":"publisher","first-page":"1088882","DOI":"10.3389\/fendo.2023.1088882","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, Sheng H, Tan Y, Zhang Q. Prevalence of diabetes in the USA from the perspective of demographic characteristics, physical indicators and living habits based on NHANES 2009\u20132018. Front Endocrinol (Lausanne). 2023;14:1088882.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"8722_CR49","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2019.19365","volume":"322","author":"YJ Cheng","year":"2019","unstructured":"Cheng YJ, Kanaya AM, Araneta MRG et al. Prevalence of Diabetes by Race and Ethnicity in the United States, 2011\u20132016. JAMA. 2019;322:2389\u20132398.","journal-title":"JAMA."},{"key":"8722_CR50","first-page":"504","volume":"32","author":"AC Adejumo","year":"2019","unstructured":"Adejumo AC, Samuel GO, Adegbala OM et al. Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States. Ann Gastroenterol. 2019;32:504\u2013513.","journal-title":"Ann Gastroenterol."},{"key":"8722_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPG.0000000000003384","volume":"74","author":"E Dybbro","year":"2022","unstructured":"Dybbro E, Dongarwar D, Salihu HM, Ihekweazu FD. Trends and Disparities in Pediatric Nonalcoholic Fatty Liver Disease-Associated Hospitalizations in the United States. J Pediatr Gastroenterol Nutr. 2022;74:503\u2013509.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8722_CR52","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/obr.12350","volume":"17","author":"E Lam","year":"2016","unstructured":"Lam E, Partridge SR, Allman-Farinelli M. Strategies for successful recruitment of young adults to healthy lifestyle programmes for the prevention of weight gain: a systematic review. Obes Rev. 2016;17:178\u2013200.","journal-title":"Obes Rev."},{"key":"8722_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/obr.12641","volume":"19","author":"N Hayba","year":"2018","unstructured":"Hayba N, Partridge SR, Nour MM, Grech A, Allman Farinelli M. Effectiveness of lifestyle interventions for preventing harmful weight gain among young adults from lower socioeconomic status and ethnically diverse backgrounds: a systematic review. Obes Rev. 2018;19:333\u2013346.","journal-title":"Obes Rev."},{"key":"8722_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024;390:497\u2013509.","journal-title":"N Engl J Med."},{"key":"8722_CR55","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387:679\u2013690.","journal-title":"Lancet."},{"key":"8722_CR56","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine. 2021;384:1113\u20131124.","journal-title":"New England Journal of Medicine."},{"key":"8722_CR57","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar N, Lee MMY, Kristensen SL et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9:653\u2013662.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"8722_CR58","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. The Lancet. 2021;398:262\u2013276.","journal-title":"The Lancet."},{"key":"8722_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4182","volume":"2","author":"LA Eberly","year":"2021","unstructured":"Eberly LA, Yang L, Essien UR et al. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US. JAMA Health Forum. 2021;2:e214182.","journal-title":"JAMA Health Forum."},{"key":"8722_CR60","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJMp2400978","volume":"390","author":"EJ Emanuel","year":"2024","unstructured":"Emanuel EJ, Dellgren JL, McCoy MS, Persad G. Fair Allocation of GLP-1 and Dual GLP-1\u2013GIP Receptor Agonists. New England Journal of Medicine. 2024;390:1839\u20131842.","journal-title":"New England Journal of Medicine."},{"key":"8722_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003763","volume":"11","author":"A-S Alexopoulos","year":"2023","unstructured":"Alexopoulos A-S, Parish A, Olsen M et al. Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis. BMJ Open Diabetes Res Care. 2023;11:e003763.","journal-title":"BMJ Open Diabetes Res Care."},{"key":"8722_CR62","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s40615-022-01324-4","volume":"10","author":"R Patil","year":"2023","unstructured":"Patil R, Nagaraj PK, Kuo H-C, Noel G. Screening and Referral Practices for Nonalcoholic Fatty Liver Disease by Race and Ethnicity in a Primary Care Clinic. J Racial Ethn Health Disparities. 2023;10:1392\u20131397.","journal-title":"J Racial Ethn Health Disparities."},{"key":"8722_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.eprac.2024.04.018","volume":"30","author":"A-S Alexopoulos","year":"2024","unstructured":"Alexopoulos A-S, Parish A, Olsen M et al. Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes. Endocr Pract. 2024;30:663\u2013669.","journal-title":"Endocr Pract."},{"key":"8722_CR64","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4254\/wjh.v12.i8.506","volume":"12","author":"P Patel","year":"2020","unstructured":"Patel P, Muller C, Paul S. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. World J Hepatol. 2020;12:506\u2013518.","journal-title":"World J Hepatol."},{"key":"8722_CR65","doi-asserted-by":"crossref","unstructured":"Hang Y, Lee C, Roman YM. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East\u00a0Asian populations. Biomark Med. 17:445\u201354.","DOI":"10.2217\/bmm-2023-0172"},{"key":"8722_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","volume":"19","author":"M Balakrishnan","year":"2021","unstructured":"Balakrishnan M, Patel P, Dunn-Valadez S et al. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2021;19:61-71.e15.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"8722_CR67","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/1535370215570189","volume":"240","author":"G Xin","year":"2015","unstructured":"Xin G, Qin S, Wang S et al. Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway. Exp Biol Med (Maywood). 2015;240:1279\u20131286.","journal-title":"Exp Biol Med (Maywood)."},{"key":"8722_CR68","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cells8101259","volume":"8","author":"C Lee","year":"2019","unstructured":"Lee C, Kim J, Jung Y. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis. Cells. 2019;8:1259.","journal-title":"Cells."},{"key":"8722_CR69","doi-asserted-by":"publisher","first-page":"10874","DOI":"10.7150\/thno.47037","volume":"10","author":"M Yang","year":"2020","unstructured":"Yang M, Liu Q, Huang T et al. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD\/NASH development. Theranostics. 2020;10:10874\u201310891.","journal-title":"Theranostics."},{"key":"8722_CR70","first-page":"S19","volume":"12","author":"A Nagral","year":"2022","unstructured":"Nagral A, Bangar M, Menezes S et al. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian J Hepatogastroenterol. 2022;12:S19-25.","journal-title":"Euroasian J Hepatogastroenterol."},{"key":"8722_CR71","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","volume":"50","author":"GSA Florentino","year":"2013","unstructured":"Florentino GSA, Cotrim HP, Vilar CP et al. Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol 2013;50:180\u2013185.","journal-title":"Arq Gastroenterol"},{"key":"8722_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"McKenzie J, Fisher BM, Jaap AJ et al. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical Endocrinology. 2006;65:40\u201344.","journal-title":"Clinical Endocrinology."},{"key":"8722_CR73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cgh.2018.08.065","volume":"17","author":"SR Sharpton","year":"2019","unstructured":"Sharpton SR, Ajmera V, Loomba R. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol. 2019;17:296\u2013306.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8722_CR74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.physbeh.2017.02.040","volume":"176","author":"K Reue","year":"2017","unstructured":"Reue K. Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities. Physiol Behav. 2017;176:174\u2013182.","journal-title":"Physiol Behav."},{"key":"8722_CR75","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1651-2227.2011.02161.x","volume":"100","author":"MZ Bardsley","year":"2011","unstructured":"Bardsley MZ, Falkner B, Kowal K, Ross JL. Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome. Acta Paediatr. 2011;100:866\u2013870.","journal-title":"Acta Paediatr."},{"key":"8722_CR76","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41467-022-28138-6","volume":"13","author":"C Lee","year":"2022","unstructured":"Lee C, Kim J, Han J et al. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis. Nat Commun. 2022;13:578.","journal-title":"Nat Commun."},{"key":"8722_CR77","doi-asserted-by":"publisher","first-page":"102071","DOI":"10.1016\/j.isci.2021.102071","volume":"24","author":"MG Novelle","year":"2021","unstructured":"Novelle MG, Bravo SB, Deshons M et al. Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation. iScience 2021;24:102071.","journal-title":"iScience"},{"key":"8722_CR78","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00018-019-03390-0","volume":"77","author":"JK DiStefano","year":"2020","unstructured":"DiStefano JK. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cell Mol Life Sci. 2020;77:2079\u20132090.","journal-title":"Cell Mol Life Sci."},{"key":"8722_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/S0007114517000046","volume":"117","author":"Y Kang","year":"2017","unstructured":"Kang Y, Kim J. Soft drink consumption is associated with increased incidence of the metabolic syndrome only in women. British Journal of Nutrition. 2017;117:315\u2013324.","journal-title":"British Journal of Nutrition."},{"key":"8722_CR80","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/nu10091263","volume":"10","author":"WS Low","year":"2018","unstructured":"Low WS, Cornfield T, Charlton CA, Tomlinson JW, Hodson L. Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding. Nutrients 2018;10:1263.","journal-title":"Nutrients"},{"key":"8722_CR81","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/osp4.360","volume":"5","author":"M Rodgers","year":"2019","unstructured":"Rodgers M, Heineman B, Dushay J. Increased fructose consumption has sex-specific effects on fibroblast growth factor 21 levels in humans. Obes Sci Pract. 2019;5:503\u2013510.","journal-title":"Obes Sci Pract."},{"key":"8722_CR82","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jnutbio.2010.06.005","volume":"22","author":"L Vil\u00e0","year":"2011","unstructured":"Vil\u00e0 L, Roglans N, Perna V et al. Liver AMP\/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem. 2011;22:741\u2013751.","journal-title":"J Nutr Biochem."},{"key":"8722_CR83","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/liv.15847","volume":"44","author":"M Kouvari","year":"2024","unstructured":"Kouvari M, Valenzuela-Vallejo L, Axarloglou E et al. Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study. Liver International. 2024;44:848\u2013864.","journal-title":"Liver International."},{"key":"8722_CR84","first-page":"258","volume":"10","author":"YS Khalid","year":"2020","unstructured":"Khalid YS, Dasu NR, Suga H et al. Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. Am J Cardiovasc Dis. 2020;10:258\u2013271.","journal-title":"Am J Cardiovasc Dis."},{"key":"8722_CR85","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, Vipani A, Bresee C et al. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. Am J Gastroenterol. 2018;113:1649\u20131659.","journal-title":"Am J Gastroenterol."},{"key":"8722_CR86","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","volume":"60","author":"J-Z Zhu","year":"2015","unstructured":"Zhu J-Z, Dai Y-N, Wang Y-M et al. Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Dig Dis Sci. 2015;60:3194\u20133202. https:\/\/doi.org\/10.1007\/s10620-015-3728-3","journal-title":"Dig Dis Sci."},{"key":"8722_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.13109","volume":"19","author":"SL Maxwell","year":"2024","unstructured":"Maxwell SL, Price JC, Perito ER, Rosenthal P, Wojcicki JM. Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx children. Pediatr Obes. 2024;19:e13109.","journal-title":"Pediatr Obes."},{"key":"8722_CR88","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/bmj.39377.622882.47","volume":"335","author":"S Friel","year":"2007","unstructured":"Friel S, Chopra M, Satcher D. Unequal weight: equity oriented policy responses to the global obesity epidemic. BMJ. 2007;335:1241\u20131243.","journal-title":"BMJ."},{"key":"8722_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00959-4","author":"S Zelber-Sagi","year":"2024","unstructured":"Zelber-Sagi S, Carrieri P, Peric\u00e0s JM et al. Food inequity and insecurity and MASLD: burden, challenges, and interventions. Nat Rev Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1038\/s41575-024-00959-4.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"8722_CR90","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/archinternmed.2011.283","volume":"171","author":"J Boone-Heinonen","year":"2011","unstructured":"Boone-Heinonen J, Gordon-Larsen P, Kiefe CI et al. Fast food restaurants and food stores: longitudinal associations with diet in young to middle-aged adults: the CARDIA study. Arch Intern Med. 2011;171:1162\u20131170.","journal-title":"Arch Intern Med."},{"key":"8722_CR91","doi-asserted-by":"publisher","first-page":"106903","DOI":"10.1016\/j.ypmed.2021.106903","volume":"154","author":"NI Heredia","year":"2022","unstructured":"Heredia NI, Zhang X, Balakrishnan M et al. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017\u20132018. Preventive Medicine 2022;154:106903.","journal-title":"Preventive Medicine"},{"key":"8722_CR92","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/hep.32207","volume":"75","author":"E Vilar-Gomez","year":"2022","unstructured":"Vilar-Gomez E, Nephew LD, Vuppalanchi R et al. High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology. 2022;75:1491\u20131506.","journal-title":"Hepatology."},{"key":"8722_CR93","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/apt.17275","volume":"56","author":"E Vilar-Gomez","year":"2022","unstructured":"Vilar-Gomez E. Editorial: food insecurity, diet quality, racial and ethnic disparities in non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 2022;56:1625\u20131626.","journal-title":"Alimentary Pharmacology & Therapeutics."},{"key":"8722_CR94","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Journal of Hepatology. 2018;68:305\u2013315.","journal-title":"Journal of Hepatology."},{"key":"8722_CR95","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.14309\/ajg.0000000000002749","volume":"119","author":"JM Paik","year":"2024","unstructured":"Paik JM, Duong S, Zelber-Sagi S et al. Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States. Am J Gastroenterol. 2024;119:1089\u20131101.","journal-title":"Am J Gastroenterol."},{"key":"8722_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190737","volume":"13","author":"G O\u2019Donoghue","year":"2018","unstructured":"O\u2019Donoghue G, Kennedy A, Puggina A et al. Socio-economic determinants of physical activity across the life course: A \u201cDEterminants of DIet and Physical ACtivity\u201d (DEDIPAC) umbrella literature review. PLoS One. 2018;13:e0190737.","journal-title":"PLoS One."},{"key":"8722_CR97","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/hep.32743","volume":"77","author":"A Kardashian","year":"2023","unstructured":"Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology. 2023;77:1382\u20131403.","journal-title":"Hepatology."},{"key":"8722_CR98","doi-asserted-by":"publisher","first-page":"1332870","DOI":"10.3389\/fpubh.2024.1332870","volume":"12","author":"RG Kim","year":"2024","unstructured":"Kim RG, Ballantyne A, Conroy MB, Price JC, Inadomi JM. Screening for social determinants of health among populations at risk for MASLD: a scoping review. Front Public Health. 2024;12:1332870.","journal-title":"Front Public Health."},{"key":"8722_CR99","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jama.2021.10413","volume":"326","author":"KJ Johnston","year":"2021","unstructured":"Johnston KJ, Hammond G, Meyers DJ, Joynt Maddox KE. Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures. JAMA. 2021;326:628\u2013636.","journal-title":"JAMA."},{"key":"8722_CR100","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep4.1831","volume":"6","author":"AM Giammarino","year":"2022","unstructured":"Giammarino AM, Qiu H, Bulsara K et al. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatol Commun. 2022;6:550\u2013560.","journal-title":"Hepatol Commun."},{"key":"8722_CR101","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00394-024-03327-9","volume":"63","author":"D Kim","year":"2024","unstructured":"Kim D, Perumpail BJ, Cholankeril G, Ahmed A. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease\/significant fibrosis measured by fibroscan. Eur J Nutr. 2024;63:995\u20131001.","journal-title":"Eur J Nutr."},{"key":"8722_CR102","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.cgh.2021.11.029","volume":"20","author":"A Kardashian","year":"2022","unstructured":"Kardashian A, Dodge JL, Terrault NA. Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis. Clin Gastroenterol Hepatol 2022;20:2790-2799.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8722_CR103","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s10620-023-08222-7","volume":"69","author":"RG Kim","year":"2024","unstructured":"Kim RG, Patel S, Satre DD et al. Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease. Dig Dis Sci. 2024;69:732\u2013742. https:\/\/doi.org\/10.1007\/s10620-023-08222-7","journal-title":"Dig Dis Sci."},{"key":"8722_CR104","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1377\/hlthaff.2019.00838","volume":"38","author":"KJ Johnston","year":"2019","unstructured":"Johnston KJ, Wen H, Joynt Maddox KE. Lack Of Access To Specialists Associated With Mortality And Preventable Hospitalizations Of Rural Medicare Beneficiaries. Health Aff (Millwood). 2019;38:1993\u20132002.","journal-title":"Health Aff (Millwood)."},{"key":"8722_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923744","volume":"10","author":"G Obita","year":"2022","unstructured":"Obita G, Alkhatib A. Disparities in the Prevalence of Childhood Obesity-Related Comorbidities: A Systematic Review. Front Public Health. 2022;10:923744.","journal-title":"Front Public Health."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08722-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T03:35:37Z","timestamp":1737689737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8722"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08722-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BG has no disclosures to report. KCM has no disclosures to report. ASA: Supported by the Duke Clinical and Translational Institute (CTSI) under award number KL2TR002554. CAM: Research support from GSK, Madrigal, Exact Sciences. Consultation\/Advisory Panels: Boehringer Ingelheim, Novo Nordisk, GLG, Sirtex. NJP: Research support from Alnylam, Amgen, Bayer, Boehringer Ingelheim, Eggland\u2019s Best, Eli Lilly, Novartis, Novo Nordisk, Merck. Consultation\/Advisory Panels for Bayer, Boehringer Ingelheim, CRISPR Therapeutics, Eli Lilly, Esperion, AstraZeneca, Merck, Novartis, and Novo Nordisk. Executive Committee member for trials sponsored by Novo Nordisk and by Amgen. DSMB for trials sponsored by J+J and Novartis. Medical advisory board for Miga Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}